BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 24182454)

  • 41. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals.
    Zaoutis TE; Foraker E; McGowan KL; Mortensen J; Campos J; Walsh TJ; Klein JD
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region.
    Tan TY; Hsu LY; Alejandria MM; Chaiwarith R; Chinniah T; Chayakulkeeree M; Choudhury S; Chen YH; Shin JH; Kiratisin P; Mendoza M; Prabhu K; Supparatpinyo K; Tan AL; Phan XT; Tran TT; Nguyen GB; Doan MP; Huynh VA; Nguyen SM; Tran TB; Van Pham H
    Med Mycol; 2016 Jul; 54(5):471-7. PubMed ID: 26868904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999-2002.
    Foongladda S; Sakulmaiwatana P; Petlum P; Vanprapar N
    J Med Assoc Thai; 2004 Jan; 87(1):92-9. PubMed ID: 14971541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bloodstream yeast infections in a university hospital in Northeast Turkey: a 4-year survey.
    Aydin F; Bayramoglu G; Guler NC; Kaklikkaya N; Tosun I
    Med Mycol; 2011 Apr; 49(3):316-9. PubMed ID: 20807028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changing epidemiology of candidaemia in Australia.
    Chapman B; Slavin M; Marriott D; Halliday C; Kidd S; Arthur I; Bak N; Heath CH; Kennedy K; Morrissey CO; Sorrell TC; van Hal S; Keighley C; Goeman E; Underwood N; Hajkowicz K; Hofmeyr A; Leung M; Macesic N; Botes J; Blyth C; Cooley L; George CR; Kalukottege P; Kesson A; McMullan B; Baird R; Robson J; Korman TM; Pendle S; Weeks K; Liu E; Cheong E; Chen S;
    J Antimicrob Chemother; 2017 Apr; 72(4):1103-1108. PubMed ID: 28364558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil.
    Almeida AA; Mesquita CS; Svidzinski TI; Oliveira KM
    Rev Soc Bras Med Trop; 2013; 46(3):335-9. PubMed ID: 23856873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.
    Purisco SU; Martins MA; Szeszs MW; Castro e Silva DM; Pukinskas SR; Bonfietti LX; Baez AA; Melhem MS
    FEMS Yeast Res; 2012 Dec; 12(8):890-6. PubMed ID: 22883021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study.
    Liu W; Tan J; Sun J; Xu Z; Li M; Yang Q; Shao H; Zhang L; Liu W; Wan Z; Cui W; Zang B; Jiang D; Fang Q; Qin B; Qin T; Li W; Guo F; Liu D; Guan X; Yu K; Qiu H; Li R;
    J Antimicrob Chemother; 2014 Jan; 69(1):162-7. PubMed ID: 24004860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014.
    Liu WL; Lai CC; Li MC; Wu CJ; Ko WC; Hung YL; Tang HJ; Hsueh PR
    J Microbiol Immunol Infect; 2019 Aug; 52(4):612-619. PubMed ID: 28886952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
    Pfaller MA; Jones RN; Doern GV; Sader HS; Hollis RJ; Messer SA
    J Clin Microbiol; 1998 Jul; 36(7):1886-9. PubMed ID: 9650930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
    Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
    Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis on clinical characteristics and drug resistance of Candida parapsilosis bloodstream infections in West China Hospital, China, from 2012 to 2015.
    Liu Y; Kang M; Ye H; Zong Z; Lv X
    J Mycol Med; 2018 Mar; 28(1):222-226. PubMed ID: 29254811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria.
    Beyer R; Spettel K; Zeller I; Lass-Flörl C; Achleitner D; Krause R; Apfalter P; Buzina W; Strauss J; Gregori C; Schüller C; Willinger B
    Mycoses; 2019 Apr; 62(4):357-367. PubMed ID: 30636016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Eleven-year retrospective survey of candidaemia in a university hospital in southwestern Greece.
    Spiliopoulou A; Vamvakopoulou S; Bartzavali C; Dimitracopoulos G; Anastassiou ED; Christofidou M
    Clin Microbiol Infect; 2010 Sep; 16(9):1378-81. PubMed ID: 20156217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Candidaemia in Sweden: a nationwide prospective observational survey.
    Ericsson J; Chryssanthou E; Klingspor L; Johansson AG; Ljungman P; Svensson E; Sjölin J
    Clin Microbiol Infect; 2013 Apr; 19(4):E218-21. PubMed ID: 23331511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
    Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
    Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.